A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study

Stefan Fruehauf Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; Center for Tumor Diagnostics and Therapy, Paracelsus Klinik, Osnabrück, GermanyCorrespondence[email protected]

Marlon Romano Veldwijk Department of Radiation Oncology, Mannheim Medical Center, University of Heidelberg, Mannheim, Germany; These authors contributed equally.

Timon Seeger Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; These authors contributed equally.

Mario Schubert Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany

Stephanie Laufs German Cancer Research Center (DKFZ), G360 Molecular Oncology of Solid Tumors, Heidelberg, Germany

Julian Topaly Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany

Patrick Wuchter Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany

Falk Dillmann Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany

Volker Eckstein Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany

Frederik Wenz Department of Radiation Oncology, Mannheim Medical Center, University of Heidelberg, Mannheim, Germany

Hartmut Goldschmidt Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany

Anthony Dick Ho Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany

Gary Calandra AnorMED Corp of Genzyme Corp, Langley, British Columbia, Canada

show all

A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date